Background. Several host-and procedure-related factors have been reported to increase the risk of permanent pacemaker (PPM) infection on the basis of descriptive analyses of case series. The purpose of this study is to assess the risk factors for PPM infection using case-control study methods.
and control subjects were matched for that particular variable, and "overall" indicates that the P value was calculated using the sum of all variables listed under the subheading.
been only 3 risk factor analyses of electrophysiologic device infection reported that included statistical modeling [8] [9] [10] , 1 [8] of which combined PPMs with implantable cardioverterdefibrillators (ICDs) in their respective statistical analyses. As demonstrated in a recent study [11] , however, the risk of infection is higher among recipients of ICDs, compared with that in patients with PPMs. Thus, a combined risk factor analysis with both types of electrophysiologic device may not be appropriate on the basis of current knowledge. In the remaining investigation [10] , which examined only PPMs, there were only 6 cases of device infection; this limited the interpretation of statistical modeling results. Therefore, the current case-control investigation was performed using multivariable analysis to better define risk factors of PPM infection.
METHODS
We performed a retrospective review of the medical records of patients with PPMs who were hospitalized at the Mayo ClinicRochester (Rochester, MN) from 1 January 1991 to 31 December 2003. Cases of PPM infection were identified using several sources, including the Division of Cardiovascular Diseases' implantable device database, the surgical index, and the computerized central diagnostic index of the Mayo Clinic [3] . Only patients whose PPM had been implanted at the Mayo ClinicRochester and who subsequently developed PPM infection were included in the study. Patients were included if they had consented to the use of their medical records for research purposes. The Mayo Foundation Institutional Review Board approved the study protocol. Definitions. PPM infection was defined as previously described by our group and others [1, 3, 12, 13] . Clinical evidence of PPM infection included local signs of inflammation at the generator pocket (e.g., erythema, warmth, fluctuance, wound dehiscence, tenderness, purulent drainage, or erosion of generator or lead through skin). PPM-related endocarditis was clinically confirmed when valvular or lead vegetations were detected by echocardiography or if the Duke criteria [14] for infective endocarditis were met. PPM infection was microbiologically confirmed on the basis of positive culture results using samples obtained from the generator pocket, lead(s), or blood (in the presence of local inflammatory signs at generator pocket or absence of another source of bacteremia and resolution of bloodstream infection after device explantation). Control selection. Noninfected control subjects were selected, using a computer-generated random selection scheme, from a database of patients whose PPM was implanted at the Mayo Clinic-Rochester from 1 January 1991 to 31 December 2003 (a total of 12,799 PPMs). Case patients were removed from the database prior to the random selection of control subjects. Two control subjects without PPM infection were identified for each case patient. To balance the 2 groups with respect to potential confounding variables, case patients and control subjects were matched by sex, age (in years ‫,)5ע‬ and date of cardiac device implantation ‫1ע(‬ year). This latter variable was included to overcome potential differences in surgical techniques, types of devices used, and prophylactic measures that could occur during the study period. Duration of followup for each control subject was as least equal to the time from device implantation to infection of the corresponding case patient.
Follow-up. All patients who underwent PPM implantation at the Mayo Clinic-Rochester were given the option to return for follow-up visits to our institution or elsewhere. Patients who chose our institution attended follow-up visits in the pacemaker clinic at 3 months after implantation for programming requirements and returned for subsequent visits at 1-year intervals. In addition, they participated in a transtelephonic monitoring system and made calls every 3 months to monitor for elective battery replacement criteria. Patients were also instructed to promptly report any signs of inflammation at the generator pocket site or onset of fever to the pacemaker clinic.
Statistical analysis. All risk factors used in the analysis were assessed at the time of PPM implantation at the Mayo Clinic-Rochester for both case patients and control subjects. Potential risk factors, represented by continuous variables, were assessed using 2-sample Student's t tests or rank-sum tests, where appropriate. Categorical variables were assessed using x 2 tests or Fisher's exact test. Risk factors for PPM infection were further assessed using both univariate and multivariable (unconditional) logistic regression models, with infection status as the dependent variable. Although case patients and control subjects were similar (as a result of matching), they were still considered to be independent experimental units, and conditional regression was not deemed to be necessary. A multivariable model was determined using logistic regression with a backward variable selection procedure, considering all variables that had P values р.10 with univariate analysis to be candidate variables. ORs were estimated using the resulting logistic models. Selected characteristics of the case patients only were assessed, for descriptive purposes. P values р.05 were considered to be statistically significant. All analyses were performed using SAS software, version 8.2 (SAS Institute).
RESULTS

From 1 January 1991 to 31 December 2003, 12,799
PPMs were implanted at the Mayo Clinic-Rochester. Potential study subjects among the patients who received these devices were identified by searching the aforementioned databases. Twenty-nine case patients and 58 control subjects met the inclusion criteria.
Characteristics of Patients with a PPM Infection
Demographic and clinical characteristics of the 29 patients who experienced a PPM infection are summarized in table 1. The mean age (‫ע‬SD) of patients at the time of PPM infection was years. Median time from device implantation to in-63 ‫ע‬ 17 fection was 204 days (mean ‫ע‬ SD, days). Heart 1116 ‫ע‬ 2484 block (60%) and sinus node disease (34%) were the most common indications for PPM implantation. In 15 patients (52%), infection developed after implantation of the original device; 14 (48%) underwent a revision procedure before they developed a subsequent PPM infection. Generator pocket infection, with or without bacteremia, was the most common clinical presentation (83%), followed by PPM-related endocarditis (10%). Staphylococcus aureus (38%) and coagulase-negative staphylococci (31%) were the leading causative agents of PPM infection (table 2) . PPM infection was complicated by distant abscess formation in 3 patients (1 patient each with septic arthritis, lung abscess, and hepatosplenic abscesses).
Management and Outcome of Cases
Pulse-generator and pacing leads were removed from all patients at the time of their initial presentation with a PPM infection. Leads were removed percutaneously in 27 patients (93%) using manual traction (in 7), locking stylet (in 10), and laser sheaths (in 10). Two patients (7%) underwent thoracotomy for lead removal. Percutaneous lead extraction was complicated by tricuspid valve laceration and incompetence in 1 patient who subsequently required valvular annuloplasty. The mean duration of antibiotic therapy for PPM infection was 21 days (median, 16 days). Patients with pocket infection were treated with 7-10 days of antibiotic therapy, and those who had device-related endocarditis received up to 6 weeks of parenteral antibiotics. Reimplantation of a new PPM was deemed to be necessary in 22 (76%) of cases. The mean time from removal of an infected device to placement of new system was 53 days (median, 7 days). Two patients died of infection-related causes during hospitalization. The mean duration of follow-up for cases was 156 weeks (median, 184 weeks). Of the 28 patients who survived the index period of hospitalization, 27 (96%) remained infection free at their last follow-up visit. One patient experienced infection of a new PPM that was thought to be caused by an infected hemodialysis catheter, with complicating bacteremia.
We subsequently analyzed a number of purported host-and procedure-related risk factors for PPM infection using univariate comparisons and a multiple logistic regression model. (table 3) . Diabetes mellitus, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease, presence of prosthetic heart valves or vascular grafts, anticoagulation, renal insufficiency, autoim- ). There was no significant difference in P p .83 risk of PPM infection between different lead placement techniques (percutaneous vs. surgical), single-versus dual-chamber leads, generator site (pectoral vs. abdominal), operator (cardiologist vs. surgeon), length of procedure (based on total fluoroscopy time), number of operators, presence of temporary pacing leads prior to device implantation, electrophysiologic study before PPM implantation, or presence of abandoned leads, as shown with univariate logistic regression (table 5) .
Postprocedure risk factors. Development of a hematoma at the generator pocket site after device placement ( ) P p .58 and duration of hospitalization had no statistically significant impact on the risk of PPM infection ( ). P p .71
Multivariable Analysis
All univariate logistic regression predictors with P values !. 10 were candidate predictors for a logistic regression model, using backward variable selection process. In the resulting multivariable model (table 5) , long-term corticosteroid use (OR, 13.9; 95% CI, 1.27-151.7;
) and the presence of 12 pacing P p .03 leads (12 leads vs. 2 leads; OR, 5.41; 95% CI, 1.44-20.29;
) were independent predictors of PPM infection. In P p .01 contrast, administration of antibiotic prophylaxis prior to device implantation had a protective effect against PPM infection when adjusted for other variables (OR, 0.087; 95% CI, 0.016-0.48;
). Previous diagnosis of malignancy (within 5 P p .005 years prior to device implantation), prior PPM infection, presence of a permanent central venous catheter, and total number of device-related procedures, although significant in univariate models, were not statistically significant predictors of increased risk of PPM infection in the multivariable model.
DISCUSSION
Sentinel results collected from 2 different large databases (National Hospital Discharge Survey and Medicare) in the United States are congruous; contemporary rates of electrophysiologic cardiac device infection are strikingly out of proportion to the rates of device placement, and this difference in rates has accelerated in recent years [2, 15] . In 1 survey [15] , there was a 49% increase in the number of new device implantations from 1996 to 2003. This observation is understandable, because indications for the use of these devices have expanded. In contrast to the number of device placements, the number of hospitalizations of patients with device infection increased by 13-fold during the same period. Interestingly, the increased infection rates differed for patients with PPM infection (2.8-fold), compared with that of patients with ICD infection (6-fold). Moreover, multivariate analysis was conducted to examine the clinical factors associated with in-hospital mortality among patients with these devices that showed that device infection was the strongest predictor of death (OR, 2.41; 95% CI, 1.58-3.66;
). The mechanisms that are operative in prompting a P ! .001 dramatic increase in the rate of electrophysiologic cardiac device infections remain largely undefined. Findings of a populationbased investigation [16] , however, may offer some explanation for the apparent rate increase in device infections. In this survey of recipients of PPMs in Olmsted County, Minnesota [16] , the mean age-adjusted Charlson comorbidity index increased from 3.15 to 4.60 over the period 1975-2004 ( ), which may P ! .001 be a driving force behind this rapid increase in rate of device infection. Thus, a risk factor analysis seems cogent in this era of increasing electrophysiologic device infection rates.
Past investigations of the electrophysiologic cardiac device infection have typically combined PPMs and ICDs in 1 group. Data generated at our institution and those described previously indicate that there are differences in the rates of PPM and ICD infection and that separate analyses, based on device type, should be performed when investigating device infection in the future. In the current survey from the Mayo Clinic, the rate of PPM infection was 0.23% (involving 29 of 12,799 patients). During the same study period, there was 110-fold rate of ICD infection (29 [1.45%] of 2001 device placements). Patients with an ICD had a higher prevalence of congestive heart failure and abdominal generator placement, and more underwent an electrophysiologic study prior to device implantation (authors' un-published data) than did patients with PPM placement. Casecontrol analysis of the cohort of patients with ICDs will be performed in a subsequent study.
A second investigation [11] performed at our institution, with a different cohort, supported the observation of an apparent increased risk of ICD infection. A population-based investigation that included residents of Olmsted County, Minnesota, from 1975 to 2004 demonstrated a difference in device infection rates. The cumulative probability of device infection was greater among patients who had an ICD, compared with those who had a PPM ( ). The overall incidence of def-P ! .001 inite device infection was 1.9 cases per 1000 device-years (95% CI, 1.1-3.1 cases per 1000 device-years); the incidences of ICD and PPM infection were 8.9 cases per 1000 device-years (95% CI, 4.2-18.6 cases per 1000 device-years) and 1.0 cases per 1000 device-years (95% CI, 0.5-2.2 cases per 1000 device-years;
), respectively.
Despite the alarming observations of device infection increases, until recently, no risk factor analysis that included statistical modeling had been described. Moreover, only 3 analyses have been reported to date [8] [9] [10] , and 1 has been limited to PPM infection [10] . In the investigation by Bertaglia et al. [10] , a primary aim was to evaluate the efficacy of single-dose cefazolin in preventing subsequent infectious complications. Only 6 (0.7%) of 852 patients developed PPM infection, which supported the notion that antibiotic prophylaxis prior to PPM placement was beneficial, and corroborated data that were described in an earlier meta-analysis of 7 randomized trials [17] . The findings of our multivariable analysis are consistent with these observations.
A second aim of the study by Bertaglia et al. [10] was to identify predictors of long-term infective complications in PPM recipients. None of the variables examined were identified as risk factors for infection on multivariable analysis, but only 6 patients developed infectious complications, and this likely limited the yield of the statistical model.
A case-control design was applied to a recently published risk factor analysis [8] among patients with either PPM or ICD infection. Thirty of 76 cases of device infection involved PPM, and the overall incidence of infection was 1.5%. Risk factors identified in this "mixed" cohort included renal insufficiency, male sex, warfarin use, congestive heart failure, and generator exchange. The number of device leads was not examined in the statistical model. Long-term corticosteroid use, however, was identified as a risk factor for PPM infection in univariate analysis (OR, 1.46; 95% CI, 0.61-16.2;
), and is con-P p .63 sistent with results from our multivariate analysis.
The third investigation [9] that has been recently published examined risk factors for the development of electrophysiologic cardiac device complications and included only patients who underwent ICD implantation. Logistic regression was used to analyze the relationship between complications and the volume of ICD implantations, per physician, among Medicare beneficiaries. The risk of ICD infection was significantly higher in patients whose ICD was implanted by physicians who had the lowest volume of implantations (OR, 2.47; 95% CI, 1.18-5.17). A statistically less rigorous study [18] was conducted at 1 institution and evaluated only PPM implantation complications. The complication rate, which included infection events, was higher among physicians who performed !12 PPM implantations per year, compared with those who implanted у12 PPMs per year. The implantation frequency per physician was not examined, however, in the current study.
The aforementioned investigations focused on host-related risk factors for PPM infection, with limited attention paid to device-or procedure-related risk factors. We analyzed a number of device characteristics and procedure-related factors in our study, including generator site, implantation technique, complexity of the device and the implantation procedure, and the use of temporary pacing wire prior to PPM placement (table  4) . Risk factors that were statistically significant were 12 procedures related to the device (by univariate analysis) and the presence of 12 pacing wires (by multivariable analysis). The presence of multiple pacing wires is a potential cause of central venous thrombosis (in the area of the leads) and has been thought to increase the risk of device infection by serving as a nidus for secondary seeding of microorganisms [19] .
Our study has several limitations. First, retrospective studies have inherent limitations, such as potential selection bias and recall bias. However, we tried to minimize these biases by collecting only objective data from the patient charts, by using a standardized case definition for device infection, and by using a computer-generated random-selection scheme for control subjects. Second, the Mayo Clinic-Rochester is a tertiary referral center, with a potential for referral bias. Third, the majority of study subjects (97%) were white, which reflected the demographic characteristics of the local population. Fourth, there is variation in generator size, lead diameter, and lead material between various pacemaker devices that depends on the manufacturing company and year of device availability (earlier models had relatively large generators). This variation in surface area of generator and lead material could affect the adherence properties of bacteria and the host inflammatory response to the device and subsequent risk of PPM infection. The specific device characteristics were not readily available. Thus, we did not statistically examine whether there was an association of these device properties and risk of device infection. More research is needed to further explore these potential relationships.
The findings of the current investigation should help to identify patients who are at increased risk of developing PPM infection. Subsequent work should be dedicated to the devel-opment of strategies to minimize the modifiable risk variables and to determine whether such modification impacts future infectious complications of PPM implantation.
